Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival - Lau, WY; Lai, EC; Leung, TW; Yu, SC (Ann Surg, 2008)